A PeRsOnalized Prevention roadmap for the future HEalThcare

Informazioni relative al progetto

PROPHET

ID dell’accordo di sovvenzione: 101057721

DOI

10.3030/101057721

Data della firma CE 20 Maggio 2022

Data di avvio 1 Settembre 2022

Data di completamento 31 Agosto 2026

Finanziato da

• Health

Costo totale

€ 2 812 437,50

Contributo UE

€ 2 812 437,00

Coordinato da

UNIVERSITA CATTOLICA DEL SACRO CUORE
Italy

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Documents, reports (10)

Report on data management and infrastructure requirements to bring research advances into Health Systems, outlining challenges and best practices

A summary of the data management needs, in alignment with the B1MG

List of process and outcome indicators for the evaluation of the clinical utility of personalized preventive approaches

Report with the list process and outcome indicators needed to evaluate the clinical utility of personalized preventive approaches

Report on biomarkers and digital technologies for risk prediction

A summary of the state of the art, opportunities & main gaps in biomarkers availability for precision prevention in the three selected areas & their integration with digital technologies for risk prediction and stratification.

Concept Paper on SRIA

A Concept Paper that include the preliminary concept towards SRIA.

Stakeholder Analysis

Analysis with stakeholder mapping and evaluation, required to the work related to D1.2

Report on clinical usefulness of biomarkers for personalized disease prevention

A summary of the evidence mapping on clinical usefulness of available biomarkers for precision prevention in the three selected areas.

Report on critical factors for the successful adoption of Personalized Prevention approaches by healthcare systems

A summary of findings from the literature mapping and survey to end users

Private sector and personal preventive information

Report on the role of the private sector, especially Direct-to-Consumer (DTC) companies, to produce personal preventive information and measures.

Report on current practices of citizens', patients', health professionals and policy makers engagement in Personalized Prevention and their gaps/bottleneck

A summary of the evidence mapping and desk research results.

Report on existing Research Programmes in the field of Personalized Prevention

A summary on existing Research programmes with a focus on the main obstacles in implementing and advancing research in the field of Personalized Prevention.

Other (1)

Stakeholder Platform

Release of the Forum, including explanation of roles, responsibilities, expectations, modus operandi

Websites, patent fillings, videos etc. (1)

Project Website

Website of the PROPHET project

Pubblicazioni

Peer reviewed articles (13)

The current landscape of personalised preventive approaches for non-communicable diseases: A scoping review

Autori: Sara Farina, Tommaso Osti, Luigi Russo, Alessandra Maio, Nicolò Scarsi, Cosimo Savoia, Abdelrahman Taha, Leonardo Villani, Roberta Pastorino, Stefania Boccia
Pubblicato in: PLOS ONE, Numero 20, 2025, ISSN 1932-6203
Editore: Public Library of Science (PLoS)
DOI: 10.1371/JOURNAL.PONE.0317379

Biomarkers for personalised prevention of chronic diseases: a common protocol for three rapid scoping reviews

Autori: E Plans-Beriso, C Babb-de-Villiers, D Petrova, C Barahona-López, P Diez-Echave, O R Hernández, N F Fernández-Martínez, H Turner, E García-Ovejero, O Craciun, P Fernández-Navarro, N Fernández-Larrea, E García-Esquinas, I Kuhn, V Jiménez-Planet, V Moreno, F Rodríguez-Artalejo, M J Sánchez, M Pollan-Santamaria, L Blackburn, M Kroese, B Pérez-Gómez
Pubblicato in: Systematic Reviews, Numero 13, 2024, ISSN 2046-4053
Editore: Springer Science and Business Media LLC
DOI: 10.1186/S13643-024-02554-9

Scanning the horizon of personalized prevention research: an overview of ongoing European funded initiatives

Autori: Alessandra Maio, Sara Farina, Tommaso Osti, Salvatore Di Grande, Roberta Pastorino, Stefania Boccia
Pubblicato in: Frontiers in Public Health, Numero 13, 2025, ISSN 2296-2565
Editore: Frontiers Media SA
DOI: 10.3389/FPUBH.2025.1561328

Indicators of the clinical utility of genetic or genomic testing: a scoping review

Autori: A Valz Gris, A Pezzullo, T Diego, M Porcelli, M Di Pumpo, N Scarsi, null null, S Boccia
Pubblicato in: European Journal of Public Health, Numero 34, 2024, ISSN 1101-1262
Editore: Oxford University Press (OUP)
DOI: 10.1093/EURPUB/CKAE144.1574

Barriers and facilitators for implementing a pharmacogenetic passport: lessons learned from reusing sequencing data

Autori: Anja H. A. Roelofsen, Loes Lindiwe Kreeftenberg, Carla G. van El, Lidewij Henneman, Tessel Rigter, Daoud Sie, Pierre M. Bet, Martina C. Cornel
Pubblicato in: Pharmacogenomics, Numero 26, 2025, ISSN 1462-2416
Editore: Informa UK Limited
DOI: 10.1080/14622416.2025.2504862

Biomarkers for Personalised Primary or Secondary Prevention in Cardiovascular Diseases: A Rapid Scoping Review

Autori: Chantal Babb de Villiers, Elena Plans-Beriso, Chaitanya Erady, Laura Blackburn, Hayley Wilson, Heather Turner, Isla Kuhn, Cristina Barahona-López, Paul Diez-Echave, Orlando Romulo Hernández, Nerea Fernández de Larrea-Baz, Dafina Petrova, Ramon Cierco Jimenez, Pablo Fernández-Navarro, Esther García-Esquinas, Fernando Rodríguez-Artalejo, María José Sánchez, Víctor Moreno, Marina Pollán, Beatriz Perez-Gomez, Mark Kroese
Pubblicato in: International Journal of Molecular Sciences, Numero 26, 2025, ISSN 1422-0067
Editore: MDPI AG
DOI: 10.3390/IJMS26199346

Sharing behavior and health care utilization following direct-to-consumer genetic testing: a systematic review

Autori: Eva Van Steijvoort, Kaatje Goossens, Kenji Demesure, Alexandra Stanczak, Maria Siermann, Pascal Borry
Pubblicato in: Open Research Europe, Numero 5, 2025, ISSN 2732-5121
Editore: F1000 Research Ltd
DOI: 10.12688/OPENRESEUROPE.19751.1

Engagement of patients and the public in personalised prevention in Europe using genomic information: a scoping review

Autori: Loes Lindiwe Kreeftenberg; Loes Lindiwe Kreeftenberg; Lidewij Henneman; Lidewij Henneman; Johannes C. F. Ket; Martina C. Cornel; Martina C. Cornel; Carla G. van El; Carla G. van El
Pubblicato in: Frontiers in Public Health, 2024, ISSN 2296-2565
Editore: Frontiers Media S.A
DOI: 10.3389/FPUBH.2024.1456853

Implementation of genetic tests for disease prevention: challenges in evidence synthesis across clinical utility domains

Autori: Angelica Valz Gris, Astrid M Vicente, Stefania Boccia
Pubblicato in: European Journal of Public Health, Numero 35, 2025, ISSN 1101-1262
Editore: Oxford University Press (OUP)
DOI: 10.1093/EURPUB/CKAF047

The PROPHET project paves the way for personalized prevention in the future healthcare

Autori: Roberta Pastorino, Angelo Maria Pezzullo, Tommaso Osti, Roza Adany, Pascal Borry, Floris Barnhoorn, Eva Fadil, Mark Kroese, Andres Metspalu, Beatriz Perez-Gomez, Markus Perola, Daniela Quaggia, Serena Scollen, Mahsa Shabani
Pubblicato in: European Journal of Cancer Prevention, 2024, ISSN 0959-8278
Editore: Wolters Kluwer Health
DOI: 10.1097/CEJ.0000000000000873

Clinician perspectives on policy approaches to genetic risk disclosure in families

Autori: Amicia Phillips; Danya F. Vears; Ine Van Hoyweghen; Pascal Borry
Pubblicato in: Familial Cancer, 2023, ISSN 1573-7292
Editore: Springer Nature B.V.
DOI: 10.1007/S10689-024-00375-2

A scoping review of the assessment reports of genetic or genomic tests reveals inconsistent consideration of key dimensions of clinical utility

Autori: Angelo Maria Pezzullo, Angelica Valz Gris, Nicolò Scarsi, Diego Maria Tona, Martina Porcelli, Matteo Di Pumpo, Peter Piko, Roza Adany, Pragathy Kannan, Markus Perola, Maria Luis Cardoso, Alexandra Costa, Astrid M. Vicente, Anu Reigo, Mariliis Vaht, Andres Metspalu, Mark Kroese, Roberta Pastorino, Stefania Boccia
Pubblicato in: Journal of Clinical Epidemiology, Numero 181, 2025, ISSN 0895-4356
Editore: Elsevier BV
DOI: 10.1016/J.JCLINEPI.2025.111729

Lawfulness in secondary use of health data

Autori: Mahsa Shabani; Sami Yilmaz
Pubblicato in: Technology and Regulation, Vol 2022 (2022), 2022, ISSN 2666-139X
Editore: Open Press TiU
DOI: 10.26116/TECHREG.2022.013